Influence of drug company authorship and sponsorship on drug trial outcomes

British Journal of Psychiatry

Volumn 191, Issue JULY, 2007, Pages 82-83

  Tungaraza, Tongeji ^a   Poole, Rob ^a,b  

^a North East Wales Trust ^*  (United Kingdom)

^b North East Wales NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTHOR; CLINICAL STUDY; DRUG INDUSTRY; EMPLOYEE; FUNDING; MEDICAL LITERATURE; OUTCOME ASSESSMENT;

AUTHORSHIP; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DRUG INDUSTRY; HUMANS; RESEARCH SUPPORT AS TOPIC;

EID: 34447117680     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.106.024547     Document Type: Article

References (7)

1. Bekelman, J. E., Li, Y. & Gross, P. C. (2003) Scope and impact of financial conflict of interest in biomedical research. A systematic review. JAMA, 289, 454-465.
2. Bodenheimer, T. (2000) Uneasy alliance. Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539-1543.
3. Djulbergovic, B., Lacevic, M., Cantor, A., et al (2000) The uncertainty principle and industry-sponsored research. Lancet, 356, 635-638.
4. Henry, D. A., Kerridge, I. H., Hill, S. R., et al (2005) Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience. Medical Journal of Australia, 182, 557-560.
5. Komsaroff, P. A. & Kerridge, I. H. (2002) Ethical issues concerning the relationship between medical practitioners and pharmaceutical industry. Medical Journal of Australia, 176, 118-121.
6. Lexchin, J., Bero, L. A., Djulbegovic, B., et al (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ, 326, 1167-1170.
7. Procyshyn, R. M., Chau, A., Fortin, P., et al (2004) Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone or olanzapine. Canadian Journal of Psychiatry, 49, 601-606.